2-29228949-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3

The NM_004304.5(ALK):​c.2750C>A​(p.Thr917Lys) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T917A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00050 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00041 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ALK
NM_004304.5 missense

Scores

6
9
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.50

Publications

1 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.81

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALKNM_004304.5 linkc.2750C>A p.Thr917Lys missense_variant Exon 16 of 29 ENST00000389048.8 NP_004295.2 Q9UM73B6D4Y2
ALKXR_001738688.3 linkn.3668+9C>A intron_variant Intron 16 of 17

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALKENST00000389048.8 linkc.2750C>A p.Thr917Lys missense_variant Exon 16 of 29 1 NM_004304.5 ENSP00000373700.3 Q9UM73
ALKENST00000618119.4 linkc.1619C>A p.Thr540Lys missense_variant Exon 15 of 28 5 ENSP00000482733.1 A0A087WZL3

Frequencies

GnomAD3 genomes
AF:
0.000502
AC:
23
AN:
45858
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000559
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000837
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000379
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000547
Gnomad OTH
AF:
0.00171
GnomAD2 exomes
AF:
0.000108
AC:
19
AN:
176352
AF XY:
0.0000715
show subpopulations
Gnomad AFR exome
AF:
0.000187
Gnomad AMR exome
AF:
0.000343
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000458
Gnomad OTH exome
AF:
0.000558
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000410
AC:
461
AN:
1123508
Hom.:
0
Cov.:
26
AF XY:
0.000457
AC XY:
252
AN XY:
551382
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000796
AC:
20
AN:
25132
American (AMR)
AF:
0.000618
AC:
17
AN:
27518
Ashkenazi Jewish (ASJ)
AF:
0.000402
AC:
8
AN:
19888
East Asian (EAS)
AF:
0.000547
AC:
17
AN:
31096
South Asian (SAS)
AF:
0.00197
AC:
92
AN:
46798
European-Finnish (FIN)
AF:
0.000537
AC:
23
AN:
42826
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4686
European-Non Finnish (NFE)
AF:
0.000297
AC:
261
AN:
879438
Other (OTH)
AF:
0.000499
AC:
23
AN:
46126
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.280
Heterozygous variant carriers
0
49
97
146
194
243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000502
AC:
23
AN:
45858
Hom.:
0
Cov.:
0
AF XY:
0.000481
AC XY:
11
AN XY:
22850
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000559
AC:
6
AN:
10740
American (AMR)
AF:
0.000837
AC:
3
AN:
3586
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2580
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2268
European-Finnish (FIN)
AF:
0.000379
AC:
1
AN:
2640
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
94
European-Non Finnish (NFE)
AF:
0.000547
AC:
12
AN:
21926
Other (OTH)
AF:
0.00171
AC:
1
AN:
586
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.247
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000213
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Jul 19, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.T917K variant (also known as c.2750C>A), located in coding exon 16 of the ALK gene, results from a C to A substitution at nucleotide position 2750. The threonine at codon 917 is replaced by lysine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.050
CADD
Pathogenic
29
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
T;.
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Benign
0.048
D
MetaRNN
Pathogenic
0.81
D;D
MetaSVM
Benign
-0.60
T
MutationAssessor
Pathogenic
3.0
M;.
PhyloP100
7.5
PrimateAI
Uncertain
0.78
T
PROVEAN
Uncertain
-3.7
D;.
REVEL
Uncertain
0.40
Sift
Uncertain
0.025
D;.
Sift4G
Uncertain
0.018
D;D
Polyphen
1.0
D;.
Vest4
0.86
MutPred
0.33
Loss of ubiquitination at K912 (P = 0.0256);.;
MVP
0.65
MPC
0.77
ClinPred
0.79
D
GERP RS
5.4
Varity_R
0.55
gMVP
0.90
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773447647; hg19: chr2-29451815; API